Terms: = Prostate cancer AND BCL2, Bcl-2, 596, ENSG00000171791
2043 results:
1. Multifaceted impact of adipose conditioned media: Obesity-driven promotion of prostate cancer and cancer stem cell dynamics.
Erdogan S; Serttas R; Dibirdik I; Turkekul K
Cell Biochem Funct; 2024 Mar; 42(2):e3979. PubMed ID: 38481004
[TBL] [Abstract] [Full Text] [Related]
2.
Kim SY; Park JE; Lee HJ; Sim DY; Ahn CH; Park SY; Shim BS; Kim B; Lee DY; Kim SH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474045
[TBL] [Abstract] [Full Text] [Related]
3. Optimizing combination therapy in prostate cancer: mechanistic insights into the synergistic effects of Paclitaxel and Sulforaphane-induced apoptosis.
Habib TN; Altonsy MO; Ghanem SA; Salama MS; Hosny MA
BMC Mol Cell Biol; 2024 Mar; 25(1):5. PubMed ID: 38438917
[TBL] [Abstract] [Full Text] [Related]
4. Combination of navitoclax (bcl-2 and Bcl-xL inhibitor) and Debio-0932 (Hsp90 inhibitor) suppresses the viability of prostate cancer cells via induction of apoptotic signaling pathway.
Asdemir A; Özgür A
Med Oncol; 2024 Mar; 41(4):83. PubMed ID: 38436810
[TBL] [Abstract] [Full Text] [Related]
5. Investigation of in-vitro Anti-cancer and Apoptotic Potential of Garlic-Derived Nanovesicles against prostate and Cervical cancer Cell Lines.
Sharma V; Sinha ES; Singh J
Asian Pac J Cancer Prev; 2024 Feb; 25(2):575-585. PubMed ID: 38415544
[TBL] [Abstract] [Full Text] [Related]
6. Effect of 5-Alpha Reductase Inhibitors on Magnetic Resonance Imaging and prostate cancer Detection.
Morote J; Picola N; Muñoz-Rodriguez J; Paesano N; Ruiz-Plazas X; Muñoz-Rivero MV; Celma A; Manuel GG; Miró B; Servian P; Abascal JM
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397430
[TBL] [Abstract] [Full Text] [Related]
7. A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin-induced apoptosis in castration-resistant prostate cancer.
Ye PC; Leu WJ; Yeh TY; Hsu YT; Lin YC; Wei ZY; Chen YC; Chiang YC; Hsu JL; Chan SH; Hsu LC; Chern JW; Yu CW; Guh JH
Prostate; 2024 May; 84(6):605-619. PubMed ID: 38375594
[TBL] [Abstract] [Full Text] [Related]
8. Pretargeted radiotherapy and synergistic treatment of metastatic, castration-resistant prostate cancer using cross-linked, PSMA-targeted lipoic acid nanoparticles.
Dai L; Zhang X; Zhou S; Li J; Pan L; Liao C; Wang Z; Chen Y; Shen G; Li L; Tian R; Sun H; Liu Z; Zhang S; Wu H
J Mater Chem B; 2024 Feb; 12(9):2324-2333. PubMed ID: 38324337
[TBL] [Abstract] [Full Text] [Related]
9. Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis.
Sugawara T; Nevedomskaya E; Heller S; Böhme A; Lesche R; von Ahsen O; Grünewald S; Nguyen HM; Corey E; Baumgart SJ; Georgi V; Pütter V; Fernández-Montalván A; Vasta JD; Robers MB; Politz O; Mumberg D; Haendler B
Mol Oncol; 2024 Mar; 18(3):726-742. PubMed ID: 38225213
[TBL] [Abstract] [Full Text] [Related]
10. Targeted anti-tumor synergistic effects of Myc decoy oligodeoxynucleotides-loaded selenium nanostructure combined with chemoradiotherapy on LNCaP prostate cancer cells.
Ghorbani R; Gharbavi M; Sharafi A; Rismani E; Rezaeejam H; Mortazavi Y; Johari B
Oncol Res; 2023; 32(1):101-125. PubMed ID: 38188680
[TBL] [Abstract] [Full Text] [Related]
11. Quality by design fostered fabrication of cabazitaxel loaded pH-responsive Improved nanotherapeutics against prostate cancer.
Shah S; Famta P; Kumar R; Sharma A; Vambhurkar G; Pandey G; Singh G; Kumar P; Mehra A; Mourya A; Srinivasarao DA; Shinde A; Prasad SB; Khatri DK; Madan J; Srivastava S
Colloids Surf B Biointerfaces; 2024 Feb; 234():113732. PubMed ID: 38181691
[TBL] [Abstract] [Full Text] [Related]
12. Vitamin K: New insights related to senescence and cancer metastasis.
Chen A; Li J; Shen N; Huang H; Hang Q
Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189057. PubMed ID: 38158025
[TBL] [Abstract] [Full Text] [Related]
13. Sinularin stabilizes FOXO3 protein to trigger prostate cancer cell intrinsic apoptosis.
Meng XY; Wang KJ; Ye SZ; Chen JF; Chen ZY; Zhang ZY; Yin WQ; Jia XL; Li Y; Yu R; Ma Q
Biochem Pharmacol; 2024 Feb; 220():116011. PubMed ID: 38154548
[TBL] [Abstract] [Full Text] [Related]
14. Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways.
Ciummo SL; Sorrentino C; Fieni C; Di Carlo E
J Exp Clin Cancer Res; 2023 Dec; 42(1):336. PubMed ID: 38087324
[TBL] [Abstract] [Full Text] [Related]
15. Resistomycin Suppresses prostate cancer Cell Growth by Instigating Oxidative Stress, Mitochondrial Apoptosis, and Cell Cycle Arrest.
Aloufi AS; Habotta OA; Abdelfattah MS; Habib MN; Omran MM; Ali SA; Abdel Moneim AE; Korany SM; Alrajhi AM
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067602
[TBL] [Abstract] [Full Text] [Related]
16. Deep learning-based whole-body characterization of prostate cancer lesions on [
Huang B; Yang Q; Li X; Wu Y; Liu Z; Pan Z; Zhong S; Song S; Zuo C
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1173-1184. PubMed ID: 38049657
[TBL] [Abstract] [Full Text] [Related]
17. Integrative bioinformatics analysis of biomarkers and pathways for exploring the mechanisms and molecular targets associated with pyroptosis in type 2 diabetes mellitus.
Wang W; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1207142. PubMed ID: 38034011
[TBL] [Abstract] [Full Text] [Related]
18. Tailored horseshoe-shaped nicotinonitrile scaffold as dual promising c-Met and Pim-1 inhibitors: Design, synthesis, SAR and in silico study.
Mohamady S; Khalil AF; Naguib BH; Nafie MS; Tawfik HO; Shaldam MA
Bioorg Chem; 2024 Feb; 143():106988. PubMed ID: 37995644
[TBL] [Abstract] [Full Text] [Related]
19. Association of triglyceride-glucose index with the risk of prostate cancer: a retrospective study.
Li T; Zhou Y; Wang J; Xiao S; Duan Y; Li C; Gao Y; An H; Tao N
PeerJ; 2023; 11():e16313. PubMed ID: 37953784
[TBL] [Abstract] [Full Text] [Related]
20. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
[Next]